Ask AI
IF13029

Pharmaceutical Patent Disputes: Biosimilar Entry Under the Biologics Price Competition and Innovation Act (BPCIA)

Published Jun 12, 2025Updated Jun 21, 2025

The Congressional Research Service is a nonpartisan policy and legal analysis arm of the Library of Congress. CRS reports are written for members of Congress and their staff, not the public — but they’re made available openly through Congress.gov.

Pharmaceutical Patent Disputes: Biosimilar Entry Under the Biologics Price Competition and… — Informed